43.67
Schlusskurs vom Vortag:
$43.29
Offen:
$43.55
24-Stunden-Volumen:
411.20K
Relative Volume:
0.59
Marktkapitalisierung:
$2.38B
Einnahmen:
$1.28B
Nettoeinkommen (Verlust:
$-222.15M
KGV:
-10.68
EPS:
-4.09
Netto-Cashflow:
$145.52M
1W Leistung:
+4.03%
1M Leistung:
-4.80%
6M Leistung:
-9.30%
1J Leistung:
-18.30%
Livanova Plc Stock (LIVN) Company Profile
Firmenname
Livanova Plc
Sektor
Branche
Telefon
4402033250662
Adresse
20 EASTBOURNE TERRACE, LONDON
Vergleichen Sie LIVN mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
LIVN
Livanova Plc
|
43.67 | 2.36B | 1.28B | -222.15M | 145.52M | -4.09 |
![]()
ABT
Abbott Laboratories
|
126.54 | 218.59B | 43.11B | 13.98B | 6.66B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
106.14 | 157.13B | 18.49B | 2.51B | 2.72B | 1.68 |
![]()
SYK
Stryker Corp
|
403.53 | 151.59B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
92.94 | 118.29B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
80.00 | 44.46B | 5.69B | 4.15B | 623.10M | 6.95 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-05-20 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
2025-02-26 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
2024-10-04 | Eingeleitet | Goldman | Buy |
2024-09-17 | Hochstufung | Robert W. Baird | Neutral → Outperform |
2024-03-20 | Bestätigt | Needham | Buy |
2024-02-20 | Hochstufung | Mizuho | Neutral → Buy |
2023-09-06 | Eingeleitet | HSBC Securities | Hold |
2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
2023-04-14 | Eingeleitet | Mizuho | Neutral |
2022-12-21 | Eingeleitet | Barclays | Equal Weight |
2022-04-06 | Eingeleitet | Wolfe Research | Outperform |
2022-02-24 | Hochstufung | UBS | Neutral → Buy |
2021-12-03 | Eingeleitet | Goldman | Buy |
2021-08-20 | Bestätigt | Needham | Buy |
2021-07-20 | Hochstufung | Needham | Hold → Buy |
2021-03-03 | Herabstufung | Berenberg | Buy → Hold |
2021-01-05 | Herabstufung | Needham | Buy → Hold |
2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
2020-06-26 | Bestätigt | Needham | Buy |
2019-10-30 | Bestätigt | Needham | Buy |
2019-02-28 | Bestätigt | Needham | Buy |
2018-11-28 | Eingeleitet | UBS | Neutral |
2018-08-02 | Bestätigt | Needham | Buy |
2018-06-08 | Eingeleitet | Stifel | Buy |
2018-05-31 | Bestätigt | Needham | Buy |
2018-02-28 | Bestätigt | Needham | Buy |
Alle ansehen
Livanova Plc Aktie (LIVN) Neueste Nachrichten
When is LivaNova PLC stock expected to show significant growthMaximize your portfolio’s earning potential - jammulinksnews.com
Why LivaNova PLC stock attracts strong analyst attention10x Return With Managed Risk - Metal.it
LivaNova’s VNS Therapy Shows Sustained Effectiveness in Drug-Resistant Epilepsy - Insider Monkey
Will LivaNova PLC stock benefit from interest rate changesFree Risk Assessment Services - jammulinksnews.com
How CPBI stock compares to its top competitorsIs LivaNova PLC stock undervalued or overvalued nowMarket-beating performance - jammulinksnews.com
What analysts say about LivaNova PLC stockMarket-leading capital gains - Autocar Professional
Is LivaNova PLC a good long term investmentHigh-impact stock picks - jammulinksnews.com
External Pacemakers Market Set to Witness Significant Growth - openPR.com
What drives LivaNova PLC stock priceBreakthrough financial growth - Autocar Professional
LivaNova PLC Stock Analysis and ForecastAccelerated wealth expansion - Autocar Professional
Cardiac Autonomic Control Market Growth in Future Scope - openPR.com
In-Line Blood Monitoring Devices Market is projected to grow - openPR.com
Wearable Cardioverter Defibrillators Market is projected - openPR.com
Jefferies Reiterates a Buy Rating on LivaNova PLC (LIVN) With a $79 PT - MSN
Neuro Modulation Devices Market is expected to reach US$ 7.6 - openPR.com
(LIVN) Technical Data - news.stocktradersdaily.com
‘A vicious life loop’: Epilepsy community calls for action to address the burden of disease - medianet.com.au
Principal Financial Group Inc. Purchases 3,668 Shares of LivaNova PLC (NASDAQ:LIVN) - Defense World
10 Undervalued Medical Device Stocks to Buy Now - Insider Monkey
How LivaNova PLC stock performs during market volatilityStable Stocks With High Yield - Newser
Vagus Nerve Stimulators Market Exclusive Report with Detailed - openPR.com
LivaNova to Announce Second-Quarter 2025 Results | LIVN Stock Ne - GuruFocus
LivaNova to Announce Second-Quarter 2025 Results - Business Wire
Finanzdaten der Livanova Plc-Aktie (LIVN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Livanova Plc-Aktie (LIVN) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Bianchi Francesco | Director |
Jun 15 '25 |
Option Exercise |
0.00 |
3,416 |
0 |
10,938 |
SCHERMERHORN TODD C | Director |
Jun 15 '25 |
Option Exercise |
0.00 |
3,416 |
0 |
9,473 |
KOZY WILLIAM A | Director |
Jun 15 '25 |
Option Exercise |
0.00 |
4,840 |
0 |
33,148 |
Barry James Christopher | Director |
Jun 15 '25 |
Option Exercise |
0.00 |
3,416 |
0 |
4,772 |
Story Brooke | Director |
Jun 15 '25 |
Option Exercise |
0.00 |
3,416 |
0 |
6,892 |
Enxing Seng Stacy | Director |
Jun 15 '25 |
Option Exercise |
0.00 |
3,416 |
0 |
12,161 |
WILVER PETER M | Director |
Jun 15 '25 |
Option Exercise |
0.00 |
3,416 |
0 |
7,148 |
Tezel Ahmet | Chief Innovation Officer |
Jun 15 '25 |
Option Exercise |
0.00 |
2,967 |
0 |
2,967 |
Bolton Stephanie | President, Global Epilepsy |
Mar 30 '25 |
Option Exercise |
0.00 |
6,024 |
0 |
15,586 |
Makatsaria Vladimir | Chief Executive Officer |
Mar 30 '25 |
Option Exercise |
0.00 |
9,330 |
0 |
9,330 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):